Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Scleraxis is required for the growth of adult tendons in response to mechanical loading
Jonathan P. Gumucio, Martin M. Schonk, Yalda A. Kharaz, Eithne Comerford, Christopher L. Mendias
Jonathan P. Gumucio, Martin M. Schonk, Yalda A. Kharaz, Eithne Comerford, Christopher L. Mendias
View: Text | PDF
Research Article Cell biology Stem cells

Scleraxis is required for the growth of adult tendons in response to mechanical loading

  • Text
  • PDF
Abstract

Scleraxis is a basic helix-loop-helix transcription factor that plays a central role in promoting tenocyte proliferation and matrix synthesis during embryonic tendon development. However, the role of scleraxis in the growth and adaptation of adult tendons is not known. We hypothesized that scleraxis is required for tendon growth in response to mechanical loading and that scleraxis promotes the specification of progenitor cells into tenocytes. We conditionally deleted scleraxis in adult mice using a tamoxifen-inducible Cre-recombinase expressed from the Rosa26 locus (ScxΔ) and then induced tendon growth in Scx+ and ScxΔ adult mice via plantaris tendon mechanical overload. Compared with the WT Scx+ group, ScxΔ mice demonstrated blunted tendon growth. Transcriptional and proteomic analyses revealed significant reductions in cell proliferation, protein synthesis, and extracellular matrix genes and proteins. Our results indicate that scleraxis is required for mechanically stimulated adult tendon growth by causing the commitment of CD146+ pericytes into the tenogenic lineage and by promoting the initial expansion of newly committed tenocytes and the production of extracellular matrix proteins.

Authors

Jonathan P. Gumucio, Martin M. Schonk, Yalda A. Kharaz, Eithne Comerford, Christopher L. Mendias

×

Figure 1

Experimental overview.

Options: View larger image (or click on image) Download as PowerPoint
Experimental overview.
(A) Overview of the alleles used to perform targe...
(A) Overview of the alleles used to perform targeted deletion of scleraxis in this study, including the constitutive CreERT2 (Rosa26CreERT2), scleraxis WT (Scx+), scleraxis floxed (Scxfl), and scleraxis loss-of-function (ScxΔ) alleles. (B) Timeline of tamoxifen treatment, synergist ablation/plantaris growth procedure, and tissue harvest. Tamoxifen was delivered on a daily basis beginning 5 days before surgery and continued through tissue harvest. (C) Overview of synergist ablation/plantaris growth procedure. A large segment of the Achilles tendon was carefully removed from the animal, resulting in compensatory hypertrophy of the synergist plantaris muscle and tendon. A neotendon area of new tendon extracellular matrix formed around the original tendon, growing in a lateral direction toward the area where the Achilles was previously located. (D and F) Relative genomic DNA (gDNA) abundance of exon 1 of scleraxis to exon 2, as measured using qPCR, in plantaris tendons of Scx+ and ScxΔ mice either 7D or 14D after synergist ablation (D) or in cultured Scx+ or ScxΔ tenocytes (F). (E and G) Expression of Scx, measured using RNAseq and quantified as transcripts per kilobase million (TPM) reads, in plantaris tendons of Scx+ and ScxΔ mice either 7D or 14D after synergist ablation (E), or in cultured Scx+ or ScxΔ tenocytes (G). Values are mean ± CV (D and F) or mean ± SD (E and G). (D and E) Differences between groups were tested using a 2-way ANOVA; a, significantly different (P < 0.05) from 7D Scx+; b, significantly different (P < 0.05) from 7D ScxΔ; c, significantly different (P < 0.05) from 14D Scx+. (F and G) Differences between groups were tested using a t test; a, significantly different (P < 0.05) from Scx+ tenocytes. N = 4 per group.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts